Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins.

Serum lipid variations in women on copper intrauterine devices, triphasic oral contraceptives and monthly injectable contraceptives.

antioxidant status in young healthy women using oral contraceptives.

Lowering of H.D.L. cholesterol by oral contraceptives.

Vitamin B6 requirements of women using oral contraceptives.

Letter: supplementary pyridoxine given to women using oral contraceptives.

Estrogens and progestins in the management of primary hyperparathyroidism.

Letter: Oral contraceptives in women over 34.

Mortality in women on oral contraceptives.

Mortality in women on oral contraceptives.

Letter: Oral contraceptives in women over 34.

Estrogens and progestins: molecular effects on brain cells.

Ceruloplasmin serum level in post-menopausal women treated with oral estrogens administered at different times.

Formulation-dependent effect of oral contraceptives on H.D.L.-cholesterol.

Oral contraceptives and nonfatal stroke in healthy young women.

Oral contraceptives and stroke in young women. Associated risk factors.

Substrate and hormonal responses to exercise in women using oral contraceptives.

Comparative studies of the ethynyl estrogens used in oral contraceptives. II. Antiovulatory potency.

Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.

Cyclical variations in mood in normal women taking oral contraceptives.

Comparative studies of the ethynyl estrogens used in oral contraceptives. I. Endometrial response.

Letter: Oral contraceptives, serum folate, and hematologic status.

Variations in serum androgens, estrogens, progestins, gonadotropins and prolactin levels in male rats from prepubertal to advanced age.

Hepatocellular carcinoma in young women on oral contraceptives.

Cell mediated immunity in healthy women taking oral contraceptives.

Suggest Documents

Serum lipid variations in women on copper intrauterine devices, triphasic oral contraceptives and monthly injectable contraceptives.

antioxidant status in young healthy women using oral contraceptives.

Lowering of H.D.L. cholesterol by oral contraceptives.

Vitamin B6 requirements of women using oral contraceptives.

Letter: supplementary pyridoxine given to women using oral contraceptives.

Estrogens and progestins in the management of primary hyperparathyroidism.

Letter: Oral contraceptives in women over 34.

Mortality in women on oral contraceptives.

Mortality in women on oral contraceptives.

Letter: Oral contraceptives in women over 34.

Estrogens and progestins: molecular effects on brain cells.

Ceruloplasmin serum level in post-menopausal women treated with oral estrogens administered at different times.

Formulation-dependent effect of oral contraceptives on H.D.L.-cholesterol.

Oral contraceptives and nonfatal stroke in healthy young women.

Oral contraceptives and stroke in young women. Associated risk factors.

Substrate and hormonal responses to exercise in women using oral contraceptives.

Comparative studies of the ethynyl estrogens used in oral contraceptives. II. Antiovulatory potency.

Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.

Cyclical variations in mood in normal women taking oral contraceptives.

Comparative studies of the ethynyl estrogens used in oral contraceptives. I. Endometrial response.

Letter: Oral contraceptives, serum folate, and hematologic status.

Variations in serum androgens, estrogens, progestins, gonadotropins and prolactin levels in male rats from prepubertal to advanced age.

Hepatocellular carcinoma in young women on oral contraceptives.

Cell mediated immunity in healthy women taking oral contraceptives.

Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins.

Recommend Documents

Follow Us